Analyst Liav Abraham works at CITI and is focused on the Healthcare sector with 269 price targets and ratings documented since 2012 spanning on 12 stocks. Analyst's average stock valuation to be materialised ratio is 62.11% with an average time for price targets to be met of 286.92 days.
Most recent stock forecast was given on ELAN, Elanco Animal Health Incorporated at 05-Aug-2021.
Liav Abraham best performing recommendations are on INSM (INSMED INCORPORATED).
The best stock recommendation documented was for TEVA (TEVA PHARMACEUTICAL INDUSTRIES LIMITED) at 11/13/2017. The price target of $13 was fulfilled within 4 days with a profit of $1.33 (11.4%) receiving and performance score of 28.49.
Average potential price target upside
Currently, out of the existing stock ratings of Liav Abraham - 14647 which are a Buy (73.85%), 4920 which are a Hold (24.81%), 266 which are a Sell (1.34%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
193
$-0.02 (-0.01%)
178
2 years 11 months 8 days ago
4/11 (36.36%)
$28.2 (13.43%)
217
Buy
203
3 years 1 months 11 days ago
1/2 (50%)
$20.22 (11.61%)
95
Hold
203
$9.98 (5.17%)
178
3 years 1 months 19 days ago
7/21 (33.33%)
$41.11 (19.94%)
305
Hold
198
$4.98 (2.58%)
188
3 years 2 months 7 days ago
4/12 (33.33%)
$58.11 (36.01%)
222
Buy
190
3 years 7 months 22 days ago
1/9 (11.11%)
$50.42 (25.65%)
280
